Scott Braunstein
2017 - Pacira Pharmaceuticals
In 2017, Scott Braunstein earned a total compensation of $1.7M as Former Chief Operating Officer at Pacira Pharmaceuticals, a 10% increase compared to previous year.
Compensation breakdown
| Bonus | $158,010 |
|---|---|
| Option Awards | $657,872 |
| Salary | $440,462 |
| Stock Awards | $486,200 |
| Other | $966 |
| Total | $1,743,510 |
Braunstein received $657.9K in option awards, accounting for 38% of the total pay in 2017.
Braunstein also received $158K in bonus, $440.5K in salary, $486.2K in stock awards and $966 in other compensation.
Rankings
In 2017, Scott Braunstein's compensation ranked 6,189th out of 14,666 executives tracked by ExecPay. In other words, Braunstein earned more than 57.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,189 out of 14,666 | 58th |
Division Manufacturing | 2,273 out of 5,772 | 61st |
Major group Chemicals And Allied Products | 721 out of 2,075 | 65th |
Industry group Drugs | 557 out of 1,731 | 68th |
Industry Pharmaceutical Preparations | 439 out of 1,333 | 67th |
Source: SEC filing on April 27, 2018.
Braunstein's colleagues
We found four more compensation records of executives who worked with Scott Braunstein at Pacira Pharmaceuticals in 2017.